Exosomes from miR-374a-5p-modified mesenchymal stem cells inhibit the progression of renal fibrosis by regulating MAPK6/MK5/YAP axis

References

• Webster AC, Nagler EV, Morton RL, et al. Chronic kidney disease. Vol. 389. (London England): Lancet; 2017. p. 1238–1252.
   Google Scholar
• Glassock RJ, Warnock DG, Delanaye P. The global burden of chronic kidney disease: estimates, variability and pitfalls. Nat Rev Nephrol. 2017;13(2):104–114.
   PubMed Web of Science ®Google Scholar
• Hercz D, Jiang SH, Webster AC. Interventions for itch in people with advanced chronic kidney disease. Cochrane Database Syst Rev. 2020;12:Cd011393.
   PubMedGoogle Scholar
• Kuppe C, Ibrahim MM, Kranz J, et al. Decoding myofibroblast origins in human kidney fibrosis. Nature. 2021;589(7841):281–286.
   PubMed Web of Science ®Google Scholar
• Sun YB, Qu X, Caruana G, et al. The origin of renal fibroblasts/myofibroblasts and the signals that trigger fibrosis. Differentiation. 2016;92(3):102–107.
   PubMed Web of Science ®Google Scholar
• Nogueira A, Pires MJ, Oliveira PA. pathophysiological mechanisms of renal fibrosis: a review of animal models and therapeutic strategies. In Vivo (Athens, Greece). 2017;31(1):1–22
   PubMed Web of Science ®Google Scholar
• Chen PS, Li YP, Ni HF. Morphology and evaluation of renal fibrosis. Adv Exp Med Biol. 2019;1165:17–36.
   PubMed Web of Science ®Google Scholar
• Zhang QF. Ulinastatin inhibits renal tubular epithelial apoptosis and interstitial fibrosis in rats with unilateral ureteral obstruction. Mol Med Rep. 2017;16(6):8916–8922.
   PubMed Web of Science ®Google Scholar
• Lan JZ, Pan Q, Tao Q, et al. TMEM45A is involved in renal fibrosis in rats by regulating Jagged1/Notch pathway. Front Biosci. 2020;25(4):593–605. (Landmark edition).
   Google Scholar
• Barnett LMA, Cummings BS. Nephrotoxicity and renal pathophysiology: a contemporary perspective. Toxicol Sci. 2018;164(2):379–390.
   PubMed Web of Science ®Google Scholar
• Tafrihi M, Hasheminasab E. MiRNAs: biology, biogenesis, their web-based tools, and databases. MicroRNA (Shariqah, United Arab Emirates). 2019;8(1):4–27.
   PubMedGoogle Scholar
• Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, et al. An overview of microRNAs: biology, functions, therapeutics, and analysis methods. J Cell Physiol. 2019;234(5):5451–5465.
   PubMed Web of Science ®Google Scholar
• Fan Y, Chen H, Huang Z, et al. Emerging role of miRNAs in renal fibrosis. RNA Biol. 2020;17(1):1–12.
   PubMed Web of Science ®Google Scholar
• Loboda A, Sobczak M, Jozkowicz A, et al. TGF-β1/Smads and miR-21 in Renal fibrosis and Inflammation. Mediators Inflamm. 2016;2016:8319283.
   PubMed Web of Science ®Google Scholar
• Lv W, Fan F, Wang Y, et al. Therapeutic potential of microRNAs for the treatment of renal fibrosis and CKD. Physiol Genomics. 2018;50(1):20–34.
   PubMed Web of Science ®Google Scholar
• Zhang W, Zhou X, Zhang H, et al. Extracellular vesicles in diagnosis and therapy of kidney diseases. Am J Physiol Renal Physiol. 2016;311(5):F844–f51.
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang L, Li C, et al. Exosome-induced regulation in Inflammatory bowel disease. Front Immunol. 2019;10:1464.
   PubMed Web of Science ®Google Scholar
• Simons M, Raposo G. Exosomes–vesicular carriers for intercellular communication. Curr Opin Cell Biol. 2009;21(4):575–581.
   PubMed Web of Science ®Google Scholar
• Barile L, Vassalli G. Exosomes: therapy delivery tools and biomarkers of diseases. Pharmacol Ther. 2017;174:63–78.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang S, Xue Z, et al. Bone mesenchymal stem cells-derived miR-223-3p-containing exosomes ameliorate lipopolysaccharide-induced acute uterine injury via interacting with endothelial progenitor cells. Bioengineered. 2021;12(2):10654–10665.
   PubMed Web of Science ®Google Scholar
• Yang S, Li X, Bi T. Exosomal microRNA-150-5p from bone marrow mesenchymal stromal cells mitigates cerebral ischemia/reperfusion injury via targeting toll-like receptor 5. Bioengineered. 2021. DOI:10.1080/21655979.2021.2012402
   Web of Science ®Google Scholar
• Wang B, Yao K, Huuskes BM, et al. Mesenchymal stem cells deliver exogenous MicroRNA-let7c via exosomes to attenuate renal fibrosis. Mol Ther. 2016;24(7):1290–1301.
   PubMed Web of Science ®Google Scholar
• Wang H, Wang B, Zhang A, et al. Exosome-mediated miR-29 transfer reduces muscle atrophy and kidney fibrosis in mice. Mol Ther. 2019;27(3):571–583.
   PubMed Web of Science ®Google Scholar
• Lee MS, Lee FY, Chen YL, et al. Investigated the safety of intra-renal arterial transfusion of autologous CD34+ cells and time courses of creatinine levels, endothelial dysfunction biomarkers and micro-RNAs in chronic kidney disease patients-phase I clinical trial. Oncotarget. 2017;8(11):17750–17762.
   PubMedGoogle Scholar
• Feng T, Li W, Li T, et al. Circular RNA_0037128 aggravates high glucose-induced damage in HK-2 cells via regulation of microRNA-497-5p/nuclear factor of activated T cells 5 axis. Bioengineered. 2021;12(2):10959–10970.
   PubMed Web of Science ®Google Scholar
• Chen H, Jin G. Downregulation of Salusin-β protects renal tubular epithelial cells against high glucose-induced inflammation, oxidative stress, apoptosis and lipid accumulation via suppressing miR-155-5p. Bioengineered. 2021;12(1):6155–6165.
   PubMed Web of Science ®Google Scholar
• Pei L, Lv X, Jia G, et al. Silencing circular RNA circ_0054537 and upregulating microRNA-640 suppress malignant progression of renal cell carcinoma via regulating neuronal pentraxin-2 (NPTX2). Bioengineered. 2021;12(1):8279–8295.
   PubMed Web of Science ®Google Scholar
• Ji Y, Ji J, Yin H, et al. Exosomes derived from microRNA-129-5p-modified tumor cells selectively enhanced suppressive effect in malignant behaviors of homologous colon cancer cells. Bioengineered. 2021;12(2):12148–12156.
   PubMed Web of Science ®Google Scholar
• Xia Q, Wang Q, Lin F, et al. miR-125a-5p-abundant exosomes derived from mesenchymal stem cells suppress chondrocyte degeneration via targeting E2F2 in traumatic osteoarthritis. Bioengineered. 2021;12(2):11225–11238.
   PubMed Web of Science ®Google Scholar
• Dong H, Wang M, and Li Q. Exosomal miR-4488 and miR-1273g-5p inhibit the epithelial-mesenchymal transition of transforming growth factor β2-mediated retinal pigment epithelial cells by targeting ATP-binding cassette A4. Bioeng. 2021;12(2):9693–9706.
   Google Scholar
• Shen C, Tao C, and Zhang A, et al. Exosomal microRNA-93-3p secreted by bone marrow mesenchymal stem cells downregulates apoptotic peptidase activating factor 1 to promote wound healing. Bioeng. 2021; 13(1):27–37.
   Google Scholar
• Wang B, Wu W, Xu K, et al. MicroRNA-223-3p is involved in fracture healing by regulating fibroblast growth factor receptor 2. Bioeng. 2021;12(2):12040–12048.
   Google Scholar
• Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018;182:27–36.
   PubMed Web of Science ®Google Scholar
• Lou G, Song X, Yang F, et al. Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma. J Hematol Oncol. 2015;8(1):122.
   PubMedGoogle Scholar
• Shang J, Sun S, Zhang L, et al. miR-211 alleviates ischaemia/reperfusion-induced kidney injury by targeting TGFβR2/TGF-β/SMAD3 pathway. Bioeng. 2020;11(1):547–557.
   Google Scholar
• Meng X, Huang W, Mo W, et al. ADAMTS-13-regulated nuclear factor E2-related factor 2 signaling inhibits ferroptosis to ameliorate cisplatin-induced acute kidney injuy. Bioeng. 2021;12(2):11610–11621.
   Google Scholar
• Yu T, Zhao C, Hou S, et al. Exosomes secreted from miRNA-29b-modified mesenchymal stem cells repaired spinal cord injury in rats. Braz J Med Biol Res = Rev Bras Pesqui Med Biol. 2019;52(12):e8735.
   PubMed Web of Science ®Google Scholar
• Chen L, Wang Y, Li S, et al. Exosomes derived from GDNF-modified human adipose mesenchymal stem cells ameliorate peritubular capillary loss in tubulointerstitial fibrosis by activating the SIRT1/eNOS signaling pathway. Theranostics. 2020;10(20):9425–9442.
   PubMed Web of Science ®Google Scholar
• Yang Y, Wang J, and Zhang Y, et al. Exosomes derived from mesenchymal stem cells ameliorate renal fibrosis via delivery of miR-186-5p. Hum Cell. 2022;35(1):83–97.
   Web of Science ®Google Scholar
• Yao T, Zha D, Hu C, et al. Circ_0000285 promotes podocyte injury through sponging miR-654-3p and activating MAPK6 in diabetic nephropathy. Gene. 2020;747:144661.
   PubMed Web of Science ®Google Scholar
• Srivastav RK, Schwede S, Klaus M, et al. Monitoring protein–protein interactions in mammalian cells by trans-SUMOylation. Biochem J. 2011;438(3):495–503.
   PubMedGoogle Scholar
• Lv LL, Feng Y, Wu M, et al. Exosomal miRNA-19b-3p of tubular epithelial cells promotes M1 macrophage activation in kidney injury. Cell Death Differ. 2020;27(1):210–226.
   PubMed Web of Science ®Google Scholar
• Chen BY, Sung CW, Chen C, et al. Advances in exosomes technology. Clin Chim Acta. 2019;493:14–19.
   PubMed Web of Science ®Google Scholar
• Nawaito SA, Sahadevan P, Clavet-Lanthier M, et al. MK5 haplodeficiency decreases collagen deposition and scar size during post-myocardial infarction wound repair. Am J Physiol Heart Circ Physiol. 2019;316(6):H1281–h96.
   PubMed Web of Science ®Google Scholar
• Seo J, Kim MH, Hong H, et al. MK5 regulates YAP stability and is a molecular target in YAP-Driven cancers. Cancer Res. 2019;79(24):6139–6152.
   PubMed Web of Science ®Google Scholar